바이오로직스 자료
Accelerating biologics development: smarter, faster and more precise assessment
A thorough understanding of target molecule characteristics is key to mitigating development risks early. With the latest update to DEVELOPICK™ 3.0, Samsung Biologics offers an in-house in silico assessment program, enabling precise molecular evaluation while securing sensitive data.
Watch the webinar to explore how the advancement enhances risk identification, molecular evaluation, and data security in the development process.
A thorough understanding of target molecule characteristics is key to mitigating development risks early. With the latest update to DEVELOPICK™ 3.0, Samsung Biologics offers an in-house in silico assessment program, enabling precise molecular evaluation while securing sensitive data.
Watch the webinar to explore how the advancement enhances risk identification, molecular evaluation, and data security in the development process.